ClinicalTrials.Veeva

Menu

Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies

C

Caen University Hospital

Status

Not yet enrolling

Conditions

Malignancies
Children, Only
Cardiovascular Diseases

Treatments

Drug: use of anticancer drugs in monotherapy or in combination therapy

Study type

Observational

Funder types

Other

Identifiers

NCT05602103
Pharmaco_112022

Details and patient eligibility

About

Little is known about cancer therapy-related cardiac dysfunction occuring in children treated by anticancer drugs for malignancies. Here the investigators use VigiBase (http://www.vigiaccess.org/), the World Health Organization (WHO) database of individual safety case reports, to identify and describe cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs.

Enrollment

10,000 estimated patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase)
  • related to children
  • and reported, or not, cancer therapy-related cardiac dysfunction

Exclusion criteria

  • cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase) related to adult patients

Trial contacts and locations

0

Loading...

Central trial contact

Joachim Alexandre, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems